ShareValue scores for NEPHROPLUS.NSE: Valuation 27, Quality 53, Growth 54, Health 55.

NEPHROPLUS.NSE
NSE

NEPHROPLUS

₹694.65(-0.29%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 10%
Valuation
27
Overvalued
Price vs Value
Quality
53
Moderate
Business Strength
Growth
54
Moderate
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

Nephrocare Health Services Limited provides dialysis healthcare services through a chain of kidney care clinics and dialysis centers in India, Uzbekistan, Nepal, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. The company was incorporated in 2009 and is based in Hyderabad, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 18, 2026
|
Last calculated:Aug 18, 2026